Literature DB >> 33805598

Targeting Intercellular Communication in the Bone Microenvironment to Prevent Disseminated Tumor Cell Escape from Dormancy and Bone Metastatic Tumor Growth.

Lauren M Kreps1,2, Christina L Addison1,2,3.   

Abstract

Metastasis to the bone is a common feature of many cancers including those of the breast, prostate, lung, thyroid and kidney. Once tumors metastasize to the bone, they are essentially incurable. Bone metastasis is a complex process involving not only intravasation of tumor cells from the primary tumor into circulation, but extravasation from circulation into the bone where they meet an environment that is generally suppressive of their growth. The bone microenvironment can inhibit the growth of disseminated tumor cells (DTC) by inducing dormancy of the DTC directly and later on following formation of a micrometastatic tumour mass by inhibiting metastatic processes including angiogenesis, bone remodeling and immunosuppressive cell functions. In this review we will highlight some of the mechanisms mediating DTC dormancy and the complex relationships which occur between tumor cells and bone resident cells in the bone metastatic microenvironment. These inter-cellular interactions may be important targets to consider for development of novel effective therapies for the prevention or treatment of bone metastases.

Entities:  

Keywords:  MDSC; angiogenesis; bone metastasis; bone remodeling; dormancy; immunosuppression; macrophage; osteoblast; osteoclast; therapy

Mesh:

Substances:

Year:  2021        PMID: 33805598      PMCID: PMC7998601          DOI: 10.3390/ijms22062911

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  327 in total

1.  Osteoclast-derived matrix metalloproteinase-9 directly affects angiogenesis in the prostate tumor-bone microenvironment.

Authors:  Alexandre Bruni-Cardoso; Lindsay C Johnson; Robert L Vessella; Todd E Peterson; Conor C Lynch
Journal:  Mol Cancer Res       Date:  2010-03-23       Impact factor: 5.852

2.  Interleukin-6 induced basic fibroblast growth factor-dependent angiogenesis in basal cell carcinoma cell line via JAK/STAT3 and PI3-kinase/Akt pathways.

Authors:  Shiou-Hwa Jee; Chia-Yu Chu; Hien-Ching Chiu; Yi-Ling Huang; Wei-Ling Tsai; Yi-Hua Liao; Min-Liang Kuo
Journal:  J Invest Dermatol       Date:  2004-12       Impact factor: 8.551

3.  Persistence of disseminated tumor cells in the bone marrow of breast cancer patients predicts increased risk for relapse--a European pooled analysis.

Authors:  Wolfgang Janni; Florian D Vogl; Gro Wiedswang; Marit Synnestvedt; Tanja Fehm; Julia Jückstock; Elin Borgen; Brigitte Rack; Stephan Braun; Harald Sommer; Erich Solomayer; Klaus Pantel; Jahn Nesland; Klaus Friese; Bjørn Naume
Journal:  Clin Cancer Res       Date:  2011-03-17       Impact factor: 12.531

4.  CD169(+) macrophages mediate pathological formation of woven bone in skeletal lesions of prostate cancer.

Authors:  Andy C Wu; Yaowu He; Amy Broomfield; Nicoll J Paatan; Brittney S Harrington; Hsu-Wen Tseng; Elizabeth A Beaven; Deirdre M Kiernan; Peter Swindle; Adrian B Clubb; Jean-Pierre Levesque; Ingrid G Winkler; Ming-Tat Ling; Bhuvana Srinivasan; John D Hooper; Allison R Pettit
Journal:  J Pathol       Date:  2016-04-27       Impact factor: 7.996

5.  Roles of activated Src and Stat3 signaling in melanoma tumor cell growth.

Authors:  Guilian Niu; Tammy Bowman; Mei Huang; Steve Shivers; Douglas Reintgen; Adil Daud; Alfred Chang; Alan Kraker; Richard Jove; Hua Yu
Journal:  Oncogene       Date:  2002-10-10       Impact factor: 9.867

6.  Dual focal adhesion kinase/Pyk2 inhibitor has positive effects on bone tumors: implications for bone metastases.

Authors:  Cedo M Bagi; Gregory W Roberts; Catharine J Andresen
Journal:  Cancer       Date:  2008-05-15       Impact factor: 6.860

7.  AZD9150, a next-generation antisense oligonucleotide inhibitor of STAT3 with early evidence of clinical activity in lymphoma and lung cancer.

Authors:  David Hong; Razelle Kurzrock; Youngsoo Kim; Richard Woessner; Anas Younes; John Nemunaitis; Nathan Fowler; Tianyuan Zhou; Joanna Schmidt; Minji Jo; Samantha J Lee; Mason Yamashita; Steven G Hughes; Luis Fayad; Sarina Piha-Paul; Murali V P Nadella; Morvarid Mohseni; Deborah Lawson; Corinne Reimer; David C Blakey; Xiaokun Xiao; Jeff Hsu; Alexey Revenko; Brett P Monia; A Robert MacLeod
Journal:  Sci Transl Med       Date:  2015-11-18       Impact factor: 17.956

Review 8.  Targeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer: modern target but ancient solution.

Authors:  Bharat B Aggarwal; Gautam Sethi; Kwang Seok Ahn; Santosh K Sandur; Manoj K Pandey; Ajaikumar B Kunnumakkara; Bokyung Sung; Haruyo Ichikawa
Journal:  Ann N Y Acad Sci       Date:  2006-12       Impact factor: 5.691

9.  Epigenetic therapy inhibits metastases by disrupting premetastatic niches.

Authors:  Zhihao Lu; Jianling Zou; Shuang Li; Michael J Topper; Yong Tao; Hao Zhang; Xi Jiao; Wenbing Xie; Xiangqian Kong; Michelle Vaz; Huili Li; Yi Cai; Limin Xia; Peng Huang; Kristen Rodgers; Beverly Lee; Joanne B Riemer; Chi-Ping Day; Ray-Whay Chiu Yen; Ying Cui; Yujiao Wang; Yanni Wang; Weiqiang Zhang; Hariharan Easwaran; Alicia Hulbert; KiBem Kim; Rosalyn A Juergens; Stephen C Yang; Richard J Battafarano; Errol L Bush; Stephen R Broderick; Stephen M Cattaneo; Julie R Brahmer; Charles M Rudin; John Wrangle; Yuping Mei; Young J Kim; Bin Zhang; Ken Kang-Hsin Wang; Patrick M Forde; Joseph B Margolick; Barry D Nelkin; Cynthia A Zahnow; Drew M Pardoll; Franck Housseau; Stephen B Baylin; Lin Shen; Malcolm V Brock
Journal:  Nature       Date:  2020-02-26       Impact factor: 69.504

10.  Downregulation of CXCR4 in Metastasized Breast Cancer Cells and Implication in Their Dormancy.

Authors:  Kentaro Nobutani; Yohei Shimono; Kiyohito Mizutani; Yuki Ueda; Toshihiro Suzuki; Midori Kitayama; Akihiro Minami; Kenji Momose; Kohta Miyawaki; Koichi Akashi; Takeshi Azuma; Yoshimi Takai
Journal:  PLoS One       Date:  2015-06-17       Impact factor: 3.240

View more
  1 in total

1.  Metastatic Prostate Cancer Cells Secrete Methylglyoxal-Derived MG-H1 to Reprogram Human Osteoblasts into a Dedifferentiated, Malignant-like Phenotype: A Possible Novel Player in Prostate Cancer Bone Metastases.

Authors:  Cinzia Antognelli; Lorella Marinucci; Roberta Frosini; Lara Macchioni; Vincenzo Nicola Talesa
Journal:  Int J Mol Sci       Date:  2021-09-22       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.